| Company Name | Date | Purpose |
|
AGI Infra
|
03-Jan-26
| AGI Infra Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/01/2026 inter alia to consider and approve the Appointment of Book Running Lead Manager to the Qualified Institutional Placement Issue. |
|
Beryl Drugs
|
03-Jan-26
| Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/01/2026 inter alia to consider and approve
1. To consider and approve the Appointment of Shailendra Pathak as an Additional Director subject to approval of shareholders in general meeting.
2. To consider and approve the Appointment of Mrs. Neha Sharda as an Independent Director subject to approval of shareholders in general meeting.
3. To consider and approve related party transaction with Aminova Infusions P. Ltd. subject to approval of shareholders in general meeting.
4. To consider and approve the resignation of Mrs. Neha Sharma from post of Company Secretary.
5. To consider and approve appointment of Mr. Kamlesh Gupta as the Company Secretary.
6. To consider and approve the date of holding EOGM.
7. Any other matter with the permission of the Chair. |
|
Beryl Securities
|
03-Jan-26
| Inter alia, consider and approve the following matters: 1. To consider and approve the resignation of Mr. Kamlesh Gupta from post of Company Secretary. 2. To consider and approve appointment of Mrs. Neha Sharma as the Company Secretary. 3. To ratify, approve and take on record the decisions taken by the Finance Committee. 4. Any other matter with the permission of the Chair. |
|
Bodhtree Consul.
|
03-Jan-26
| Bodhtree Consulting Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/01/2026 inter alia to consider and approve To consider and approve the proposal for merger of Rzeninfo Solutions Private Limited into the Company (Bodhtree) and its related matters. |
|
Cupid Breweries
|
03-Jan-26
| Preferential Issue of shares & Increase in Authorised Capital Inter alia, to take note of the detailed deliberations undertaken by the Board at its meeting held on November 27, 2025 in relation to the proposed preferential issue / private placement of securities for consideration other than cash, and to consider and, if thought fit, approve the proposal for issuance of securities on a preferential basis, including determination of the issue price, at the meeting scheduled to be held on January 03, 2026, subject to such regulatory and statutory approvals as may be required, including the approval of the shareholders of the Company, and to transact other incidental and ancillary matters |